TCL Archive Conversation with The Cancer Letter: Statistician Lori Dodd Saw Research Question In the Midst of 2007 ODAC Debate Over Avastin By Cancer History Project July 27, 2012
TCL Archive FDA Approves Afinitor-Aromasin Regimen For Advanced HER2-Negative Breast Cancer By Cancer History Project July 27, 2012
TCL Archive Phase III Study Evaluating Halaven Fails To Meet Primary Endpoints By Cancer History Project July 27, 2012
TCL Archive Upper Endoscopy Most Effective When Performed in 3-Year Intervals By Cancer History Project July 27, 2012
TCL Archive Women Who Concieve Using Fertility Drugs Have a Higher Risk Of Breast Cancer Than Non-Users By Cancer History Project July 27, 2012
TCL Archive Variation in Breast Density May Be Strong Risk Factor By Cancer History Project July 27, 2012
TCL Archive Study: Molecular Breast Imaging Can Be As Effective as MRI By Cancer History Project July 27, 2012
Article Robert Mayer talks about the half-century of misses that preceded the development of daraxonrasib By Cancer History Project
Primary Source Backwater to Blockbuster: St. Jude Children’s Research Hospital By Cancer History Project
